|Bid||329.20 x 900|
|Ask||331.10 x 1100|
|Day's Range||327.27 - 334.68|
|52 Week Range||224.22 - 341.70|
|Beta (5Y Monthly)||0.37|
|PE Ratio (TTM)||49.40|
|Earnings Date||Nov 01, 2022|
|Forward Dividend & Yield||3.92 (1.19%)|
|Ex-Dividend Date||Aug 12, 2022|
|1y Target Est||304.28|
The success of Biogen (BIIB)-Eisai's AD candidate in a big phase III study makes investors optimistic about the prospects of other AD candidates as well.
Dow Jones futures fell as Treasury yields rebounded, signaling Wednesday's rally may be short-lived. Eli Lilly leads some bullish stocks.
In this article, we discuss 11 best dividend-paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their returns, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. Dividend companies are gaining ground among investors this year as they navigate the rocky market. In times of financial […]